Enyedy Mark J

Officer, Director at ImmunoGen, Inc.

Sold, on record
$53M
Dollars the filings state
Form 4 sales
5
Latest Feb 5, 2024
Form 144 notices
4
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale ImmunoGen, Inc.Plan not stated
    Feb 22 2018

    Sold 51,070 shares at $5.60 ($286k)

    Enyedy Mark J, Chief Executive Officer

    Sold 9.5% of holdings ($3M position)483,768 shares leftFiling

  2. 2 Form 4 sale ImmunoGen, Inc.Plan not stated
    Feb 24 +732 days

    Sold 55,222 shares at $4.99 ($276k)

    Enyedy Mark J, Chief Executive Officer

    Sold 11.3% of holdings ($2.4M position)433,776 shares leftFirst sale on recordFiling

  3. 3 Form 144 notice ImmunoGen, Inc.Notice
    Aug 2 +1255 days

    Filed to sell 995,157 shares ($17.4M)

    Enyedy Mark J, Officer, Director

    No 10b5-1 planFirst sale on recordFiling

  4. 4 Form 144 notice ImmunoGen, Inc.Notice
    Aug 3 +1 day

    Filed to sell 1M shares ($16.9M)

    Enyedy Mark J, Officer, Director

    No 10b5-1 planFirst sale on recordFiling

  5. 5 Form 4 sale ImmunoGen, Inc.Unusual
    Aug 4 +1 day

    Sold 3M shares at $17.01 ($51.1M)

    Enyedy Mark J, CHIEF EXECUTIVE OFFICER

    No 10b5-1 planSold 84.5% of holdings ($60.6M position)553,270 shares leftFirst sale on recordFollows a Form 144Filing

  6. 6 Form 144 notice ImmunoGen, Inc.Notice
    Aug 4 same day

    Filed to sell 992,397 shares ($16.8M)

    Enyedy Mark J, Officer, Director

    No 10b5-1 planFirst sale on recordFiling

  7. 7 Form 144 notice ImmunoGen, Inc.Notice
    Feb 5 +185 days

    Filed to sell 20,107 shares ($589k)

    Enyedy Mark J, Officer, Director

    10b5-1 planFiling

  8. 8 Form 4 sale ImmunoGen, Inc.Routine
    Feb 5 same day

    Sold 20,107 shares at $29.28 ($589k)

    Enyedy Mark J, CHIEF EXECUTIVE OFFICER

    10b5-1 planSold 3.3% of holdings ($17.7M position)584,397 shares leftFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (9)

Form 144 notices and Form 4 sales by Enyedy Mark J
Source
Feb 5, 2024ImmunoGen, Inc.CHIEF EXECUTIVE OFFICERForm 4 sale20,107$589k3.3%RoutineSEC
Feb 5, 2024ImmunoGen, Inc.Officer, DirectorForm 144 notice20,107$589kNoticeSEC
Aug 4, 2023ImmunoGen, Inc.Officer, DirectorForm 144 notice992,397$16.8MNoticeSEC
Aug 4, 2023ImmunoGen, Inc.CHIEF EXECUTIVE OFFICERForm 4 sale3M$51.1M84.5%UnusualSEC
Aug 3, 2023ImmunoGen, Inc.Officer, DirectorForm 144 notice1M$16.9MNoticeSEC
Aug 2, 2023ImmunoGen, Inc.Officer, DirectorForm 144 notice995,157$17.4MNoticeSEC
Feb 24, 2020ImmunoGen, Inc.Chief Executive OfficerForm 4 sale55,222$276k11.3%Plan not statedSEC
Feb 22, 2018ImmunoGen, Inc.Chief Executive OfficerForm 4 sale51,070$286k9.5%Plan not statedSEC
Feb 21, 2018ImmunoGen, Inc.Chief Executive OfficerForm 4 sale67,717$736k11.3%Plan not statedSEC